Does increased intestinal permeability reflected by elevated zonulin promote immune activation and associate with autoimmune thyroid disease?

The hypothesis that increased intestinal permeability is associated with immune activation and autoimmune thyroid diseases, such as Hashimoto's thyroiditis and Graves' disease, is strongly supported by mechanistic and clinical research.

Biological mechanisms of barrier disruption

• Zonulin signaling: Zonulin acts as a physiological modulator of intestinal tight junctions. It binds to the proteinase-activated receptor 2 (PAR2) and transactivates the epidermal growth factor receptor (EGFR). This signaling cascade activates protein kinase C (PKC) alpha, which induces the reversible disassembly of tight junction proteins like claudin-1, claudin-2, and occludin.
• Antigen translocation: This tight-junction disassembly opens paracellular channels, enabling the translocation of luminal antigens, macromolecular dietary proteins, and microbial cell wall components (e.g., lipopolysaccharide, or LPS) from the gut lumen into the lamina propria and the systemic circulation.
• Immune activation: Once inside the lamina propria, translocated antigens bind to pattern-recognition receptors (such as Toll-like receptors) on dendritic cells and macrophages. This initiates an inflammatory cascade, triggering T-cell activation and the production of pro-inflammatory cytokines (including TNF-alpha, IFN-gamma, and IL-17). These cytokines form a feed-forward loop, further damaging tight junctions and sustaining systemic immune activation.

Clinical evidence in autoimmune thyroid disease

• Hashimoto's thyroiditis: Clinical and observational studies demonstrate that patients with Hashimoto's thyroiditis have significantly elevated serum zonulin levels compared to healthy controls. Notably, pediatric cohorts show elevated zonulin levels regardless of thyroid hormone status, and positive correlations exist between circulating zonulin and thyroid peroxidase (TPO) antibodies.
• Graves' disease: Patients with new-onset Graves' disease also show marked elevations in markers of intestinal permeability, including serum zonulin, LPS, and D-lactate. These elevated barrier markers correlate directly with circulating TSH receptor antibody (TRAb) levels.
• Methodological context: While zonulin is a valuable clinical indicator of barrier status, some commercial assays face specificity challenges and may cross-react with other haptoglobin-like proteins, showing variable correlation with functional lactulose-mannitol recovery tests. Furthermore, current evidence is primarily observational and cross-sectional; thus, it remains unclear whether barrier dysfunction acts as a primary initiator of thyroid autoimmunity or represents a secondary effect of systemic inflammation.

Bottom line

Increased intestinal permeability and elevated zonulin levels are strongly associated with both Hashimoto's thyroiditis and Graves' disease. Mechanistically, zonulin-induced tight junction disassembly allows luminal antigens to enter systemic circulation, driving the immune activation that underlies thyroid-directed autoimmunity. While this pathway is clinically and mechanistically validated, further longitudinal research is needed to determine if restoring barrier integrity can directly modify the course of autoimmune thyroid disease.